微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -55.57% | -75.63% | -45.81% | 144/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -38.11% | -34.1% | -154.58% | 144/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -14.97% | -15.51% | 79.28% | 142/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -72.25% | -62.98% | -128.35% | 145/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -31.64% | -43.75% | -11.33% | 147/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -28.42% | -132.38% | -119.29% | 147/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -12.96% | -174% | 70.76% | 142/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -44.33% | -23.62% | -101.41% | 141/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -22.01% | 26.49% | -79.97% | 142/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -12.23% | 57.33% | -158.56% | 141/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -4.73% | 63.62% | 86.81% | 137/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -35.86% | 28.18% | -19.77% | 141/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -29.94% | 2% | -4.47% | 138/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -28.66% | 2% | -120.46% | 144/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -13% | 2% | 73.96% | 134/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -49.93% | 2% | 2% | 143/158 | 0.79% | ST人福 | 6.82% | 行业排名> |